Tetra Bio-Pharma

About:

Tetra Bio-Pharma is a biopharmaceutical company that focuses on cannabinoid-based drug development for inflammation, pain, and more.

Website: https://tetrabiopharma.com/

Twitter/X: tetrabiopharma

Top Investors: Alpha Blue Ocean, Ministère de l'Économie et de l'Innovation

Description:

Tetra Bio-Pharma is a biopharmaceutical company that focuses on cannabinoid-based drug discovery and development with a clinical program. Tetra Bio-Pharma specializes in combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio-pharma industry by regulators, physicians, and insurance companies.

Total Funding Amount:

$47.5M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Ottawa, Ontario, Canada

Founded Date:

2007-05-17

Contact Email:

investors(AT)tetrabiopharma.com

Founders:

Guy Chamberland, Ryan Brown

Number of Employees:

11-50

Last Funding Date:

2022-08-11

IPO Status:

Public

Industries:

© 2025 bioDAO.ai